These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26010091)

  • 21. A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome.
    Jensterle M; Kravos NA; Pfeifer M; Kocjan T; Janez A
    Hormones (Athens); 2015; 14(1):81-90. PubMed ID: 25885106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liraglutide: New Perspectives for the Treatment of Polycystic Ovary Syndrome.
    Papaetis GS; Filippou PK; Constantinidou KG; Stylianou CS
    Clin Drug Investig; 2020 Aug; 40(8):695-713. PubMed ID: 32583294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiometabolic Effects of Chronic Hyperandrogenemia in a New Model of Postmenopausal Polycystic Ovary Syndrome.
    Dalmasso C; Maranon R; Patil C; Bui E; Moulana M; Zhang H; Smith A; Yanes Cardozo LL; Reckelhoff JF
    Endocrinology; 2016 Jul; 157(7):2920-7. PubMed ID: 27145003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of vertical sleeve gastrectomy on a rat model of polycystic ovarian syndrome.
    Wilson-Pérez HE; Seeley RJ
    Endocrinology; 2011 Oct; 152(10):3700-5. PubMed ID: 21810946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study.
    Jensterle M; Pirš B; Goričar K; Dolžan V; Janež A
    Eur J Clin Pharmacol; 2015 Jul; 71(7):817-24. PubMed ID: 25991051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consequences of advanced aging on renal function in chronic hyperandrogenemic female rat model: implications for aging women with polycystic ovary syndrome.
    Patil CN; Racusen LC; Reckelhoff JF
    Physiol Rep; 2017 Nov; 5(20):. PubMed ID: 29051304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reproductive and metabolic phenotype of a mouse model of PCOS.
    van Houten EL; Kramer P; McLuskey A; Karels B; Themmen AP; Visser JA
    Endocrinology; 2012 Jun; 153(6):2861-9. PubMed ID: 22334715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of WBN/Kob diabetic fatty rats supplemented with a fructose-rich diet as a metabolic syndrome model: response to a GLP-1 receptor agonist.
    Namekawa J; Nemoto S; Sunada G; Takanashi Y; Fujio S; Shirai M; Asai F
    J Vet Med Sci; 2018 Oct; 80(10):1515-1523. PubMed ID: 30175725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization on gut microbiome of PCOS rats and its further design by shifts in high-fat diet and dihydrotestosterone induction in PCOS rats.
    Zheng Y; Yu J; Liang C; Li S; Wen X; Li Y
    Bioprocess Biosyst Eng; 2021 May; 44(5):953-964. PubMed ID: 32157446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Prevented Weight Regain in Obese Women with Polycystic Ovary Syndrome Previously Treated with Liraglutide: A Pilot Randomized Study.
    Ferjan S; Janez A; Jensterle M
    Metab Syndr Relat Disord; 2017 Dec; 15(10):515-520. PubMed ID: 29064743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systematic review of GLP-1 agonists on the metabolic syndrome in women with polycystic ovaries.
    Niafar M; Pourafkari L; Porhomayon J; Nader N
    Arch Gynecol Obstet; 2016 Mar; 293(3):509-15. PubMed ID: 26660657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism.
    Rajan RK; M SS; Balaji B
    Pharm Biol; 2017 Dec; 55(1):242-251. PubMed ID: 27927075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liraglutide modulates adipokine expression during adipogenesis, ameliorating obesity, and polycystic ovary syndrome in mice.
    Singh A; Fernandes JRD; Chhabra G; Krishna A; Banerjee A
    Endocrine; 2019 May; 64(2):349-366. PubMed ID: 30904998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of dehydroepiandrosterone-treated rats is not a good animal model for the study of metabolic abnormalities in polycystic ovary syndrome.
    Seow KM; Ting CH; Huang SW; Ho LT; Juan CC
    Taiwan J Obstet Gynecol; 2018 Oct; 57(5):696-704. PubMed ID: 30342654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dihydrotestosterone deteriorates cardiac insulin signaling and glucose transport in the rat model of polycystic ovary syndrome.
    Tepavčević S; Vojnović Milutinović D; Macut D; Žakula Z; Nikolić M; Božić-Antić I; Romić S; Bjekić-Macut J; Matić G; Korićanac G
    J Steroid Biochem Mol Biol; 2014 May; 141():71-6. PubMed ID: 24472754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndrome.
    Siamashvili M; Davis SN
    Expert Rev Clin Pharmacol; 2021 Sep; 14(9):1081-1089. PubMed ID: 34015974
    [No Abstract]   [Full Text] [Related]  

  • 37. Kisspeptin in the Hypothalamus of 2 Rat Models of Polycystic Ovary Syndrome.
    Osuka S; Iwase A; Nakahara T; Kondo M; Saito A; Bayasula ; Nakamura T; Takikawa S; Goto M; Kotani T; Kikkawa F
    Endocrinology; 2017 Feb; 158(2):367-377. PubMed ID: 27983870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocrine traits of polycystic ovary syndrome in prenatally androgenized female Sprague-Dawley rats.
    Wu XY; Li ZL; Wu CY; Liu YM; Lin H; Wang SH; Xiao WF
    Endocr J; 2010; 57(3):201-9. PubMed ID: 20057162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperandrogenism and Insulin Resistance, Not Changes in Body Weight, Mediate the Development of Endothelial Dysfunction in a Female Rat Model of Polycystic Ovary Syndrome (PCOS).
    Hurliman A; Keller Brown J; Maille N; Mandala M; Casson P; Osol G
    Endocrinology; 2015 Nov; 156(11):4071-80. PubMed ID: 26322372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential Strain-dependent Ovarian and Metabolic Responses in a Mouse Model of PCOS.
    Binder AK; Peecher DL; Qvigstad AJ; Gutierrez SD; Magaña J; Banks DB; Korach KS
    Endocrinology; 2023 Feb; 164(4):. PubMed ID: 36718579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.